01 1M/s Wockhardt limited
01 1Insuline Glargine (Recombinant)
01 1WC-0414
01 1India
Insuline Glargine (Recombinant)
Date of Issue : 2017-11-07
Valid Till : 2020-11-07
Written Confirmation Number : WC-0414
Address of the Firm : Biotech Park, H-14/2 MIDC Waluj Aurangabad-431136 Maharashtra India
A Glargine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glargine, including repackagers and relabelers. The FDA regulates Glargine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glargine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glargine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glargine supplier is an individual or a company that provides Glargine active pharmaceutical ingredient (API) or Glargine finished formulations upon request. The Glargine suppliers may include Glargine API manufacturers, exporters, distributors and traders.
click here to find a list of Glargine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glargine written confirmation (Glargine WC) is an official document issued by a regulatory agency to a Glargine manufacturer, verifying that the manufacturing facility of a Glargine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glargine APIs or Glargine finished pharmaceutical products to another nation, regulatory agencies frequently require a Glargine WC (written confirmation) as part of the regulatory process.
click here to find a list of Glargine suppliers with Written Confirmation (WC) on PharmaCompass.
LOOKING FOR A SUPPLIER?